Former bodybuilder Tony McCue began stumbling and 'dropping things' two years ago. After being diagnosed with locked-in ...
Patients increasingly complain that it is difficult to win approval from health insurance companies for certain types of ...
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Voyager ...
15h
News Medical on MSNExploring how 25-hydroxycholesterol triggers ferroptosis in glial cellsOxysterols are a class of molecules derived from cholesterol via oxidation or as byproducts of cholesterol synthesis.
LOS ANGELES, CA / ACCESS Newswire / February 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
6h
News Medical on MSNNeurofilament light as a translational biomarker from preclinical drug discovery to clinical applicationNeurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Voyager Therapeutics, Inc. ("Voyager" or "the Company") (NASDAQ: ...
It isn’t unusual for the University of Utah’s women’s gymnastics program to bring awareness to causes or institutions that the team values. Every year, the Red Rocks have a military appreciation night ...
The past decade has seen a dramatic increase in the technology that allows the detection of minute amounts of disease-related analytes in biofluids. This is ...
18h
The Brighterside of News on MSNResearchers unlock the secret to reversing age-related muscle declineA new study from the University of Ottawa’s Faculty of Medicine sheds light on a potential breakthrough in treating muscle ...
Of the first four experimental ALS treatments tested in the HEALEY platform trial, CNM-Au8 and pridopridine showed some promising results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results